ScholarLens Back to search
2007•Unpublished venueRequires access

Heparin, low molecular weight heparin

Raphaëlle Dumaine, Gilles Montalescot

Open publisher page 1 citations

Abstract

Platelet glycoprotein IIb/IIIa (GPIIb/IIIa) receptor inhibitors are widely used to prevent thrombotic vascular events, especially in patients with acute coronary syndromes (ACS) or in those undergoing intravascular interventional procedures. The purpose of this chapter is to evaluate the quality and magnitude of the clinical trial evidence in support of their use. In addition, key issues regarding their optimal application in clinical practice will be discussed.

About this research paper

What this paper is about

Platelet glycoprotein IIb/IIIa (GPIIb/IIIa) receptor inhibitors are widely used to prevent thrombotic vascular events, especially in patients with acute coronary syndromes (ACS) or in those undergoing intravascular interventional procedures. The purpose of this chapter is to evaluate the quality and magnitude of the clinical trial evidence in support of their use. In addition, key issues regarding their optimal application in clinical practice will be discussed.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Platelet glycoprotein IIb/IIIa (GPIIb/IIIa) receptor inhibitors are widely used to prevent thrombotic vascular events, especially in patients with acute coronary syndromes (ACS) or in those undergoing intravascular interventional procedures. The purpose of this chapter is to evaluate the quality and magnitude of the clinical trial evidence in support of their use. In addition, key issues regarding their optimal application in clinical practice will be discussed.

Key concepts: Heparin, Low molecular weight heparin, Medicine, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Heparin, low molecular weight heparin — Research Paper | ScholarLens